16/09/2024
|
07:00
|
Related Party Transaction
|
RNS
|
16/09/2024
|
07:00
|
Ondine announces Board Changes
|
RNS
|
06/08/2024
|
07:00
|
Leeds Teaching Hospital NHS Trust to use Steriwave
|
RNS
|
28/06/2024
|
17:45
|
Result of AGM and Voting Results
|
RNS
|
07/06/2024
|
07:00
|
2023 Full Year Results and Annual Report
|
RNS
|
06/06/2024
|
07:00
|
Notice of AGM and Directorate Change
|
RNS
|
28/05/2024
|
07:00
|
Notice of Results, Investor Presentation, and AGM
|
RNS
|
13/05/2024
|
09:30
|
NOTIFICATION OF MAJOR HOLDINGS
|
RNS
|
08/05/2024
|
07:00
|
Further Result of Fundraising
|
RNS
|
03/05/2024
|
16:27
|
Result of Fundraising
|
RNS
|
03/05/2024
|
08:00
|
Ondine announces proposed fundraising
|
RNS
|
02/05/2024
|
18:25
|
Related Party Transactions
|
RNS
|
24/04/2024
|
07:00
|
Corporate and Trading Update
|
RNS
|
28/03/2024
|
12:52
|
Appointment of Interim Chief Financial Officer
|
RNS
|
25/03/2024
|
07:00
|
First commercial adoption of Steriwave by the NHS
|
RNS
|
26/01/2024
|
07:00
|
Grant of Share Options
|
RNS
|
16/01/2024
|
08:15
|
Appointment of new Chief Financial Officer
|
RNS
|
12/12/2023
|
13:20
|
TR-1: NOTIFICATION OF MAJOR HOLDINGS
|
RNS
|
11/12/2023
|
18:15
|
Result of Fundraising
|
RNS
|
05/12/2023
|
07:00
|
Result of Placing & Broker Option Update
|
RNS
|
04/12/2023
|
13:28
|
Close of Bookbuild
|
RNS
|
01/12/2023
|
18:13
|
Update. Re investor-led financing
|
RNS
|
30/11/2023
|
18:40
|
Ondine announces investor-led financing
|
RNS
|
16/11/2023
|
07:00
|
Photodisinfection recommended as Standard of Care
|
RNS
|
25/09/2023
|
09:00
|
Half-year Report
|
RNS
|
30/08/2023
|
07:00
|
Notice of Results and Investor Presentation
|
RNS
|
21/08/2023
|
07:00
|
Issue of Equity and TVR
|
RNS
|
01/08/2023
|
07:00
|
Ondine commences first NHS Steriwave® pilot
|
RNS
|
07/07/2023
|
17:58
|
Corporate Update
|
RNS
|
25/05/2023
|
07:00
|
Result of AGM
|
RNS
|
23/05/2023
|
07:00
|
Annual Report for the Year Ended 31 December 2022
|
RNS
|
10/05/2023
|
07:09
|
Full Year Results
|
RNS
|
03/05/2023
|
15:30
|
Notice of Results and Investor Presentation
|
RNS
|
03/05/2023
|
08:02
|
Notice of AGM
|
RNS
|
03/05/2023
|
07:56
|
Issue of Equity
|
RNS
|
17/04/2023
|
07:00
|
Progress Update
|
RNS
|
03/03/2023
|
07:00
|
Ottawa hospital presents Steriwave study results
|
RNS
|
22/02/2023
|
07:00
|
Grant of Share Options
|
RNS
|
31/01/2023
|
12:01
|
Ondine’s APDT reduces SARS-CoV-2 infectivity
|
RNS
|
17/01/2023
|
10:04
|
TR-1: Notification of major holdings
|
RNS
|
13/01/2023
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
13/01/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
30/12/2022
|
12:31
|
Appointment of Nominated Adviser
|
RNS
|
12/12/2022
|
07:00
|
Steriwave receives regulatory approval in Mexico
|
RNS
|
02/12/2022
|
07:00
|
Ondine reports full results from Phase 2 trial
|
RNS
|
04/11/2022
|
07:00
|
PDMR Dealing
|
RNS
|
28/10/2022
|
07:00
|
PDMR Dealing
|
RNS
|
19/10/2022
|
11:36
|
Steriwave™ cuts SSI risk by 47% at major hospital
|
RNS
|
27/09/2022
|
07:00
|
Interim results for the six months to 30 June 2022
|
RNS
|
23/09/2022
|
09:00
|
The Ottawa Hospital pilots nasal disinfection
|
RNS
|